Leszek Tylicki, Bogdan Biedunkiewicz, Dominik Rachon, Tomasz Nieweglowski, Lukasz Hak, Andrzej Chamienia, Alicja Debska-Slizien, Ewa Aleksandrowicz, Jolanta Mysliwska, Boleslaw Rutkowski, "No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients", Mediators of Inflammation, vol. 13, Article ID 983494, 4 pages, 2004. https://doi.org/10.1080/09629350400014131
No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients
BACKGROUND: Ozone as a strong oxidant may induce an inflammatory response.Aim: The hypothesis was verified as to whether ozonated autohemotherapy using an ozone dose in therapeutic range changes the plasma concentration of C-reactive protein and interleukin-6, markers of inflammation.Methods: In a controlled, single-blind, cross-over study, 12 chronically hemodialyzed patients with peripheral arterial disease were exposed to nine sessions of autohemotherapy with blood exposure to oxygen as a control followed by nine sessions of ozonated autohemotherapy with an ozone concentration of 50 μg/ml.Results: There was no statistical difference between C-reactive protein levels at baseline (1.53±1.01 mg/l), after nine sessions of control autohemotherapy (1.48±0.96 mg/l), and after nine sessions of ozonated autohemotherapy (1.55±0.84 mg/l). There was also no statistical difference between the interleukin-6 serum concentration at baseline (438±118 pg/ml), after nine sessions of control autohemotherapy (444±120 pg/ml), and after nine sessions of ozonated autohemotherapy (466±152 pg/ml).Conclusion: The results of this study suggest that ozonated autohemotherapy using an ozone concentration of 50 μg/ml does not induce an inflammatory response.
Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.